PharmacoEconomics promotes the continuing development and study of pharmacoeconomics, outcomes research and quality-of-life assessment as applied to optimum drug therapy and health outcomes, providing a practical economic background to informed clinical prescribing decisions and allocation of healthcare resources. The Journal includes:
Leading/current opinion articles providing an overview of contentious or emerging issues.
Definitive reviews of topics relating to the pharmacoeconomic and quality-of-life assessment of healthcare interventions and their outcomes.
Original research articles.
Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in PharmacoEconomics may be accompanied by plain language summaries to assist readers in understanding important medical advances.
All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.